Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Fibrinolytic factors and inhibitors; plasmin

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 85400 refers to a laboratory test that measures the activity of plasmin, a crucial serine protease enzyme produced by the liver. In its inactive form, plasminogen circulates in the bloodstream until it binds to a clot or cell surface, where it is activated into plasmin. This activation process is facilitated by various agents, including tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), kallikrein, and factor XII (Hageman). Once activated, plasmin plays a vital role in the breakdown of plasma proteins, particularly in the process of fibrinolysis, where it dissolves fibrin clots. Additionally, plasmin activates collagenases and contributes to the weakening of the walls of Graafian follicles, which is essential for ovulation. Beyond its role in reproductive health, plasmin is integral to wound healing, liver repair, and maintaining liver homeostasis. The test involves obtaining a blood sample through a separately reportable venipuncture, followed by analysis using fluorimetry to accurately measure plasmin activity.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The laboratory test associated with CPT® Code 85400 is indicated for various clinical scenarios where the measurement of plasmin activity is necessary. The following conditions may warrant this test:

  • Assessment of Fibrinolytic Activity This test is performed to evaluate the fibrinolytic system's functionality, particularly in patients with suspected thrombotic disorders.
  • Monitoring of Thrombolytic Therapy It is used to monitor patients undergoing thrombolytic therapy to ensure effective clot dissolution and to assess the risk of bleeding complications.
  • Investigation of Coagulation Disorders The test aids in diagnosing and managing patients with coagulation disorders that may involve abnormal plasmin activity.

2. Procedure

The procedure for conducting the test associated with CPT® Code 85400 involves several key steps to ensure accurate measurement of plasmin activity. The following procedural steps are outlined:

  • Step 1: Patient Preparation Prior to the test, the patient may be instructed to avoid certain medications or foods that could interfere with the results. It is essential to ensure that the patient is adequately informed about the procedure.
  • Step 2: Venipuncture A blood sample is obtained through a venipuncture, which is a separately reportable procedure. The site is cleaned, and a needle is inserted into a vein to collect the blood sample into appropriate collection tubes.
  • Step 3: Sample Processing Once the blood sample is collected, it is processed in the laboratory. This may involve centrifugation to separate plasma from blood cells, ensuring that the sample is suitable for testing.
  • Step 4: Fluorimetry Testing The plasma sample is then analyzed using fluorimetry, a technique that measures the fluorescence emitted by the plasmin in the sample. This allows for the quantification of plasmin activity.
  • Step 5: Result Interpretation After the analysis, the results are interpreted by qualified laboratory personnel, and the findings are reported to the requesting physician for further clinical decision-making.

3. Post-Procedure

After the procedure, patients may experience minor discomfort at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for this test, but patients should be advised to monitor the site for any unusual symptoms, such as excessive bleeding or signs of infection. The results of the plasmin activity test will be communicated to the healthcare provider, who will discuss the implications of the findings and any necessary follow-up actions based on the results.

Short Descr FIBRINOLYTIC PLASMIN
Medium Descr FIBRINOLYTIC FACTORS & INHIBITORS PLASMIN
Long Descr Fibrinolytic factors and inhibitors; plasmin
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
Pre-1990 Added Code added.
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"